Head and Neck Neoplasm — Trials

Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,801–1,850 of 1,990 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06383780	Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.	recruiting	Phase 3	90	XIANG YANQUNOTHER	1	Jul 16, 2024	clinicaltrials
NCT06438627	Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial	recruiting	Phase 3	164	XIANG YANQUNOTHER	1	Jul 16, 2024	clinicaltrials